Refine Results
  1. "Carol Aghajanian"
Formats
  1. Journal Article (203)
  2. Meeting Abstract (178)
  3. Book Section (1)
Groups
  1. Solid Tumor Oncology Division (382)
  2. Gynecologic Medicine Service (274)
  3. Gynecologic Oncology Disease Management Team (186)
  4. Surgery (132)
  5. Gynecologic Medicine Service (108)
  6. Epidemiology and Biostatistics (95)

More Groups

People
  1. Carol Aghajanian (382)
  2. Paul Sabbatini (106)
  3. David Spriggs (105)
  4. Martee Hensley (82)
  5. Jason Konner (64)
  6. Alexia Iasonos (60)

More People

Years
  1. 2020 (16)
  2. 2019 (44)
  3. 2018 (21)
  4. 2017 (27)
  5. 2016 (13)
  6. 2015 (23)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Gynecologic Oncology (107)
  3. International Journal of Gynecological Cancer (31)
  4. Clinical Cancer Research (20)
  5. Annals of Oncology (19)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (11)

More Publications

Publishers
  1. Elsevier Inc. (122)
  2. American Society of Clinical Oncology (109)
  3. American Association for Cancer Research (39)
  4. Lippincott Williams & Wilkins (33)
  5. Oxford University Press (20)
  6. Nature Publishing Group (12)

More Publishers

Results (382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer
    Journal Article

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H.; O'Cearbhaill, R.; Aghajanian, C. A.; Schilder, R.
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma
    Journal Article

    Mueller, J. J.; Pedra Nobre, S.; Braxton, K.; Alektiar, K. M.; Leitao, M. M. Jr; Aghajanian, C.; Ellenson, L. H.; Abu-Rustum, N. R.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Randomized phase II trial of nivolumab versus nivolumab and ipilimumab for recurrent or persistent ovarian cancer: An NRG Oncology study
    Journal Article

    Zamarin, D.; Burger, R. A.; Sill, M. W.; Powell, D. J. Jr; Lankes, H. A.; Feldman, M. D.; Zivanovic, O.; Gunderson, C.; Ko, E.; Mathews, C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: A phase II trial
    Journal Article

    Zamarin, D.; Walderich, S.; Holland, A.; Zhou, Q.; Iasonos, A. E.; Torrisi, J. M.; Merghoub, T.; Chesebrough, L. F.; Mcdonnell, A. S.; Gallagher, J. M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer
    Journal Article

    Myers, A. P.; Konstantinopoulos, P. A.; Barry, W. T.; Luo, W.; Broaddus, R. R.; Makker, V.; Drapkin, R.; Liu, J.; Doyle, A.; Horowitz, N. S.; more...
    International Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): Post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
    Journal Article

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Impact of provider imaging practices on survival outcomes in advanced ovarian cancer
    Journal Article

    Green, A. K.; Korenstein, D.; Aghajanian, C.; Barrow, B.; Curry, M.; O'Cearbhaill, R. E.
    Journal of the National Comprehensive Cancer Network (2020)

    Fulltext@MSK | Save
  • Concordance between immunohistochemistry for DNA mismatch repair proteins and next generation sequencing for the identification of microsatellite instability in endometrial cancer
    Meeting Abstract

    Da Cruz Paula, A.; DeLair, D.; Fix, D.; Soslow, R.; Park, K.; Chiang, S.; Reis-Filho, J.; Zehir, A.; Mandelker, D.; Murali, R.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Concordance of p53 immunohistochemistry and TP53 mutation status in endometrial cancer
    Meeting Abstract

    Da Cruz Paula, A.; DeLair, D.; Fix, D.; Soslow, R.; Park, K.; Chiang, S.; Reis-Filho, J.; Zehir, A.; Murali, R.; Makker, V.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save